The development of targeted cancer therapies has revolutionized patient outcomes, and at the heart of these advancements lie sophisticated chemical syntheses. Brigatinib, a significant drug used in the treatment of ALK-positive non-small cell lung cancer, is a prime example. The intricate process of creating Brigatinib relies heavily on the availability of high-quality chemical intermediates, with 1-Methyl-4-(Piperidin-4-yl)-Piperazine (CAS 53617-36-0) being one of the most crucial. Understanding the chemistry of this intermediate is key to appreciating its value in pharmaceutical manufacturing.

1-Methyl-4-(Piperidin-4-yl)-Piperazine is characterized by its molecular formula C10H21N3 and a molecular weight of 183.294 g/mol. Its physical properties, such as an off-white to gray solid appearance and a melting point between 53-56°C, are important considerations for handling and processing. The chemical's structure, incorporating a piperazine ring attached to a piperidine ring via a methyl group, provides specific reactive sites that are essential for its incorporation into the Brigatinib molecular framework. This structural precision is what makes it an indispensable 1-Methyl-4-(Piperidin-4-yl)-Piperazine intermediate.

NINGBO INNO PHARMCHEM CO.,LTD. specializes in providing fine chemicals and pharmaceutical intermediates that meet rigorous industry standards. Our expertise in producing 1-Methyl-4-(Piperidin-4-yl)-Piperazine ensures that our clients receive a product with high purity, vital for the demanding synthesis of oncology drugs. The consistent supply of this compound from reliable 1-Methyl-4-(Piperidin-4-yl)-Piperazine suppliers in China is critical for uninterrupted drug production, allowing pharmaceutical companies to focus on delivering therapies to patients.

The market for Brigatinib intermediates is competitive, and NINGBO INNO PHARMCHEM CO.,LTD. distinguishes itself through its commitment to quality and customer service. By providing essential pharmaceutical building blocks like 1-Methyl-4-(Piperidin-4-yl)-Piperazine, we contribute to the advancement of medicinal chemistry and the fight against cancer. The ongoing research into novel therapeutic agents often draws upon similar chemical scaffolds, highlighting the broader significance of such intermediates in pharmaceutical innovation.